Clinical significance of early recurrence after pulmonary vein antrum isolation in paroxysmal atrial fibrillation – Insight into the mechanism

Circulation Journal

Volumn 79, Issue 11, 2015, Pages 2353-2359

  Miyazaki, Shinsuke ^a   Taniguchi, Hiroshi ^a   Nakamura, Hiroaki ^a   Takagi, Takamitsu ^a   Iwasawa, Jin ^a   Hachiya, Hitoshi ^a   Iesaka, Yoshito ^a  

^a TSUCHIURA KYODO GENERAL HOSPITAL   (Japan)

Author keywords

Catheter ablation; Early recurrence; Paroxysmal atrial fibrillation; Pulmonary vein isolation

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN;

ADULT; ARTICLE; ATRIAL FIBRILLATION; CARDIOVASCULAR MORTALITY; CATHETER ABLATION; CHADS2 SCORE; EARLY RECURRENCE OF ATRIAL FIBRILLATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PAROXYSMAL ATRIAL FIBRILLATION; PULMONARY VEIN ISOLATION; RETROSPECTIVE STUDY; ADVERSE EFFECTS; AGED; CHI SQUARE DISTRIBUTION; DISEASE FREE SURVIVAL; HEART RATE; KAPLAN MEIER METHOD; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; PULMONARY VEIN; RECURRENT DISEASE; REOPERATION; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME;

AGED; ATRIAL FIBRILLATION; CATHETER ABLATION; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; FEMALE; HEART RATE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PULMONARY VEINS; RECURRENCE; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84944769220     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-15-0475     Document Type: Article

References (25)

1. Haïssaguerre M, Jaïs P, Shah DC, Garrigue S, Takahashi A, Lavergne T, et al. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation 2000; 101: 1409-1417.
2. Nault I, Miyazaki S, Forclaz A, Wright M, Jadidi A, Jaïs P, et al. Drugs vs. ablation for the treatment of atrial fibrillation: The evidence supporting catheter ablation. Eur Heart J 2010; 31: 1046-1054.
3. JCS Joint Working Group. Guidelines for non-pharmacotherapy of cardiac arrhythmias (JCS 2011): Digest version. Circ J 2013; 77: 249-274.
4. Miyazaki S, Taniguchi H, Kusa S, Uchiyama T, Nakamura H, Hachiya H, et al. Impact of atrial fibrillation termination site and termination mode in catheter ablation on arrhythmia recurrence. Circ J 2014; 78: 78-84.
5. Oral H, Knight BP, Ozaydin M, Tada H, Chugh A, Hassan S, et al. Clinical significance of early recurrences of atrial fibrillation after pulmonary vein isolation. J Am Coll Cardiol 2002; 40: 100-104.
6. Richter B, Gwechenberger M, Socas A, Marx M, Gössinger HD. Frequency of recurrence of atrial fibrillation within 48 hours after ablation and its impact on long-term outcome. Am J Cardiol 2008; 101: 843-847.
7. Lellouche N, Jaïs P, Nault I, Wright M, Bevilacqua M, Knecht S, et al. Early recurrences after atrial fibrillation ablation: Prognostic value and effect of early reablation. J Cardiovasc Electrophysiol 2008; 19: 599-605.
8. Koyama T, Tada H, Sekiguchi Y, Arimoto T, Yamasaki H, Kuroki K, et al. Prevention of atrial fibrillation recurrence with corticosteroids after radiofrequency catheter ablation: A randomized controlled trial. J Am Coll Cardiol 2010; 56: 1463-1472.
9. Saad EB, d’Avila A, Costa IP, Aryana A, Slater C, Costa RE, et al. Very low risk of thromboembolic events in patients undergoing suc cessful catheter ablation of atrial fibrillation with a CHADS2 score ≤3: A long-term outcome study. Circ Arrhythm Electrophysiol 2011; 4: 615-621.
10. Andrade JG, Macle L, Khairy P, Khaykin Y, Mantovan R, De Martino G, et al. Incidence and significance of early recurrences associated with different ablation strategies for AF: A STAR-AF substudy. J Cardiovasc Electrophysiol 2012; 23: 1295-1301.
11. Kornej J, Hindricks G, Kosiuk J, Arya A, Sommer P, Husser D, et al. Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry. Circ Arrhythm Electrophysiol 2014; 7: 281-287.
12. Andrade JG, Khairy P, Macle L, Packer DL, Lehmann JW, Holcomb RG, et al. Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation: Insights from the multicenter Sustained Treatment of Paroxysmal Atrial Fibrillation (STOP AF) Trial. Circ Arrhythm Electrophysiol 2014; 7: 69-75.
13. Maroto LC, Carnero M, Silva JA, Cobiella J, Pérez-Castellano N, Reguillo F, et al. Early recurrence is a predictor of late failure in surgical ablation of atrial fibrillation. Interact Cardiovasc Thorac Surg 2011; 12: 681-686.
14. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Heart Rhythm 2012; 9: 632-696.
15. Miyazaki S, Kuwahara T, Kobori A, Takahashi Y, Takei A, Sato A, et al. Long-term clinical outcome of extensive pulmonary vein isolation- based catheter ablation therapy in patients with paroxysmal and persistent atrial fibrillation. Heart 2011; 97: 668-673.
16. Takagi T, Miyazaki S, Kusa S, Taniguchi H, Ichihara N, Iwasawa J, et al. Role of extended external auto-triggered loop recorder monitoring for atrial fibrillation: Validation and utility after catheter ablation procedures. Circ J 2014; 78: 2637-2642.
17. Patel D, Mohanty P, Di Biase L, Sanchez JE, Shaheen MH, Burkhardt JD, et al. Outcomes and complications of catheter ablation for atrial fibrillation in females. Heart Rhythm 2010; 7: 167-172.
18. Takigawa M, Kuwahara T, Takahashi A, Watari Y, Okubo K, Takahashi Y, et al. Differences in catheter ablation of paroxysmal atrial fibrillation between males and females. Int J Cardiol 2013; 168: 1984-1991.
19. Verma A, Champagne J, Sapp J, Essebag V, Novak P, Skanes A, et al. Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): A prospective, multicenter study. JAMA Intern Med 2013; 173: 149-156.
20. Weerasooriya R, Khairy P, Litalien J, Macle L, Hocini M, Sacher F, et al. Catheter ablation for atrial fibrillation: Are results maintained at 5 years of follow-up? J Am Coll Cardiol 2011; 57: 160-166.
21. Richter B, Gwechenberger M, Socas A, Zorn G, Albinni S, Marx M, et al. Markers of oxidative stress after ablation of atrial fibrillation are associated with inflammation, delivered radiofrequency energy and early recurrence of atrial fibrillation. Clin Res Cardiol 2012; 101: 217-225.
22. Lim HS, Schultz C, Dang J, Alasady M, Lau DH, Brooks AG, et al. Time course of inflammation, myocardial injury, and prothrombotic response after radiofrequency catheter ablation for atrial fibrillation. Circ Arrhythm Electrophysiol 2014; 7: 83-89.
23. Jiang RH, Po SS, Tung R, Liu Q, Sheng X, Zhang ZW, et al. Incidence of pulmonary vein conduction recovery in patients without clinical recurrence after ablation of paroxysmal atrial fibrillation: Mechanistic implications. Heart Rhythm 2014; 11: 969-976.
24. Nakagawa H, Scherlag BJ, Patterson E, Ikeda A, Lockwood D, Jackman WM. Pathophysiologic basis of autonomic ganglionated plexus ablation in patients with atrial fibrillation. Heart Rhythm 2009; 6: S26-S34.
25. Katritsis DG, Pokushalov E, Romanov A, Giazitzoglou E, Siontis GC, Po SS, et al. Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fibrillation: A randomized clinical trial. J Am Coll Cardiol 2013; 62: 2318-2325.